Reported 32,786,348 shares, unchanged from the prior quarter.
Reported value 16.1%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-12-31 | 8500000 |
| 2023-03-31 | 11033234 |
| 2023-06-30 | 15824810 |
| 2023-09-30 | 5872685 |
| 2023-12-31 | 0 |
| 2024-06-30 | 181133332 |
| 2024-09-30 | 534904544 |
| 2024-12-31 | 435861716 |
| 2025-03-31 | 471155646 |
| 2025-06-30 | 717624887 |
| 2025-09-30 | 696716643 |
| 2025-12-31 | 636479692 |
| 2026-03-31 | 689974554 |
| 2026-06-30 | 477697090 |
| 2026-09-30 | 554417145 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 32,786,348 | 0 (0.0%) | 2.63% | $554,417,145 | 2026-11-16 | |
| Q2 2026 | Reduced | 32,786,348 | -3,604,715 (-9.9%) | 2.39% | $477,697,090 | 2026-08-14 | |
| Q1 2026 | Unchanged | 36,391,063 | 0 (0.0%) | 3.96% | $689,974,554 | 2026-05-15 | |
| Q4 2025 | Added | 36,391,063 | +2,668,089 (7.9%) | 3.73% | $636,479,692 | 2026-02-17 | |
| Q3 2025 | Unchanged | 33,722,974 | 0 (0.0%) | 5.03% | $696,716,643 | 2025-11-14 | |
| Q2 2025 | Added | 33,722,974 | +9,298,109 (38.1%) | 6.96% | $717,624,887 | 2025-08-14 | |
| Q1 2025 | Unchanged | 24,424,865 | 0 (0.0%) | 5.21% | $471,155,646 | 2025-05-15 | |
| Q4 2024 | Unchanged | 24,424,865 | 0 (0.0%) | 4.66% | $435,861,716 | 2025-02-14 | |
| Q3 2024 | Added | 24,424,865 | +1,202,643 (5.2%) | 5.54% | $534,904,544 | 2024-11-14 | |
| Q2 2024 | New | 23,222,222 | +23,222,222 (0.0%) | 2.31% | $181,133,332 | 2024-08-14 | |
| Q4 2023 | Reduced | 0 | -3,140,473 (-100.0%) | 0 | $0 | 2024-02-14 | |
| Q3 2023 | Reduced | 3,140,473 | -3,164,232 (-50.2%) | 0.03% | $5,872,685 | 2023-11-14 | |
| Q2 2023 | Unchanged | 6,304,705 | 0 (0.0%) | 0.09% | $15,824,810 | 2023-08-14 | |
| Q1 2023 | Added | 6,304,705 | +4,304,705 (215.2%) | 0.06% | $11,033,234 | 2023-05-15 | |
| Q4 2022 | New | 2,000,000 | +2,000,000 (0.0%) | 0.05% | $8,500,000 | 2023-02-14 |
Who else reported the position
334 managers reported SUMMIT THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BAKER BROS ADVISORS LP This report | Unchanged | 32,786,348 | 0 | 2.63% | $554,417,145 | 10 qtrs |
| BlackRock Inc | Added | 10,363,750 | +834,709 | < 0.01% | $175,251,012 | 9 qtrs |
| FMR LLC | Reduced | 8,136,745 | -1,907,202 | < 0.01% | $137,592,355 | 14 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 7,230,441 | +1,495,957 | < 0.01% | $122,266,757 | 3 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 6,717,642 | +1,675,452 | < 0.01% | $113,595,326 | 3 qtrs |
| STATE STREET CORPORATION | Reduced | 6,093,474 | -3,443,322 | < 0.01% | $103,040,645 | 16 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 5,296,215 | +1,402,395 | < 0.01% | $89,560,000 | 14 qtrs |
| CITADEL ADVISORS LLC | Added | 3,783,589 | +2,057,873 | < 0.01% | $63,980,490 | 11 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 3,489,224 | +61,961 | < 0.01% | $59,015,572 | 25 qtrs |
| Kynam Capital Management LP | Added | 3,000,000 | +1,800,000 | 2.81% | $50,730,000 | 2 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 32,786,348
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.